Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in Transcatheter Aortic Valve Implantation (TAVI)

Trial Profile

Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in Transcatheter Aortic Valve Implantation (TAVI)

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Apr 2017

At a glance

  • Drugs Aspirin (Primary) ; Clopidogrel (Primary)
  • Indications Intracranial embolism
  • Focus Therapeutic Use
  • Acronyms DAPT-TAVI
  • Most Recent Events

    • 26 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top